All speakers (symposiast, oral presentation, poster presentation) need to submit an abstract. Abstract
submissions are open until Friday August 31 2012.
Please follow the formatting guidelines below.
1. Abstracts must be written in English, and must not exceed one page for all presenters. There is no
limitation in length for symposiast. Please use Century font size, 10.5 pts for text (see “example”).
2. The name of the presenting author should be underlined.
3. Please send your abstract (both word and PDF files) to ugas@kobe-u.ac.jp by attached mail.
4. Title of your submission mail must be “APCPZ Abstract”.
For questions, please inquire at ugas@kobe-u.ac.jp .
Authors should submit an Abstract in advance (see Abstract Submission).
The height and the width of a poster board should be 1.8 m x 0.9 m. Authors are requested to
be in front of their poster during the official session time (From 11:45 am to 12:15 pm on
Poster mounting should be completed on Saturday morning (Oct.6) at the latest. The drawing
pin and cellophane tape used for mounting will be prepared at the registration desk. Posters
should be removed by 2:00 pm on Sunday. After this deadline, staff members will dismount
Shoji Uga1, Kenji Kimura1, Jun-ichiro Yanagida1, Shinichi Noda2, Junichi Gy
1Department to Parasitology, Faculty of Health Sciences, Kobe University Graduate School of Health Sciences, Kobe, Japan; 2Research Center for the Pacific Islands, Kagoshima University, Kogoshima, Japan; 3Departmen
r ical Research and Education, School of Medicine, Ehime University, Ehime,
Japan; presentation author 4National Institute of Malariology, Parasitology and Entomology, Hanoi, Vietnam
theprevalence after the second treatment was
prevalence of soil transmitted helminth (STH)
significantly lower than the control (55%). This
though single treatment is known to limit its effect
tendency was more remarkable for the third
due to re-infection. We examined the control of STH
treatment. Of the 356 students who received a third
infection in an endemic area of Vietnam by
treatment 15% showed positive for STH shortly after
repeating treatments of primary school students
the third treatment, followed by 30% after six months
once a year for three years. Fecal examination
and 38% after one year of the treatment. Prevalence of
performed in October 2005, before the first
STH before the first treatment (55%) and one year
treatment by mebendazol, showed 55% of 471
after the third treatment (38%) was significantly
students were positive for parasites. Two weeks
different (chi- square test; p < 0.01). Mebendazol
after the first treatment, the prevalence decreased
treatment was effective against A. lumbricoides
to25% but it became 47% one year later. Pre valence
fertilized egg, which occupied 86% of total number
rates of two weeks and one year after the second
of eggs recovered throughout the survey.
treatment were 25% and 42%, respectively.
Our survey result suggests that repeated treatment
Although change of prevalence after the s
treatment was same as that of the first treat
Characters: 47 per line, 10.5pt Pitch Lines: 28 per page, 25pt Pitch Margins: top27, bottom21, left18, right18 Order: 1. Title 2. Author 3. Affiliation 4. Text * It has to be within one page.
Trigeminusneuralgie Was gibt es Neues? • Medikamentöse Therapie: Es gibt keine neuen Pharmaka zur medikamentösen Prophylaxe der • Operative Therapie: Auch die radiochirurgische Behandlung der Trigeminusneuralgie mittels Gamma-Knife oder Linearbeschleuniger ist grundsätzlich wirksam, jedoch im Hinblick auf die Langzeitergebnisse den klassischen operativen Verfahren unterlegen. D
Abstract: My essay is engaging with the discussion about the Father's fault, if any, in the Fall of mankind. After exploring some other works in the research library as well as the Bible itself, I compiled this work. It is obvious that the Father is not complicit in the fall of man. No excuse of man can absolve him of his guilt. “I made him just and right, / Sufficient to have stood,